Hsd:WI |
neonatal body weight |
control condition |
Rothermund L, etal., J Hypertens. 2006 Sep 24(9). |
body mass |
not specified |
12 days
| 0 |
22.8 |
g |
0.4 |
|
body weighing method |
0.0 |
0 |
108080 |
3115 |
Hsd:WI |
neonatal body weight |
control condition |
Rothermund L, etal., J Hypertens. 2006 Sep 24(9). |
body mass |
not specified |
7 days
| 0 |
14.3 |
g |
0.2 |
|
body weighing method |
0.0 |
0 |
108078 |
3115 |
Hsd:WI |
body weight |
1H-pyrazole (10 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
body mass |
male |
0 days
| 6 |
142.5 |
g |
0.73 |
1.8 |
body weighing method |
0.0 |
0 |
75953 |
1544 |
Hsd:WI |
body weight |
silymarin (50 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
body mass |
male |
0 days
| 6 |
143.6 |
g |
0.41 |
1.0 |
body weighing method |
0.0 |
0 |
75954 |
1544 |
Hsd:WI |
body weight |
octylphenol (125 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
body mass |
male |
119 days-126 days |
6 |
326.67 |
g |
14.98 |
36.69 |
body weighing method |
0.0 |
0 |
76047 |
1545 |
Hsd:WI |
body weight |
control condition |
Rothermund L, etal., J Hypertens. 2006 Sep 24(9). |
body mass |
not specified |
100 days
| 0 |
376.0 |
g |
8.0 |
|
body weighing method |
0.0 |
0 |
108082 |
3115 |
Hsd:WI |
body weight |
bisphenol A (250 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
body mass |
male |
119 days-126 days |
6 |
336.83 |
g |
12.66 |
31.0 |
body weighing method |
0.0 |
0 |
76044 |
1545 |
Hsd:WI |
change in body weight to body weight ratio |
bisphenol A (250 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
body mass |
male |
119 days-126 days |
6 |
215.9 |
% |
15.19 |
37.2 |
body weighing method |
0.0 |
0 |
76067 |
1545 |
Hsd:WI |
body weight |
bisphenol A (125 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
body mass |
male |
119 days-126 days |
6 |
314.83 |
g |
6.15 |
15.07 |
body weighing method |
0.0 |
0 |
76042 |
1545 |
Hsd:WI |
change in body weight to body weight ratio |
vehicle control condition (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
body mass |
male |
119 days-126 days |
5 |
255.0 |
% |
13.42 |
30.0 |
body weighing method |
0.0 |
0 |
76065 |
1545 |
Hsd:WI |
change in body weight to body weight ratio |
octylphenol (125 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
body mass |
male |
119 days-126 days |
6 |
242.2 |
% |
18.74 |
45.9 |
body weighing method |
0.0 |
0 |
76068 |
1545 |
Hsd:WI |
change in body weight to body weight ratio |
octylphenol (250 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
body mass |
male |
119 days-126 days |
6 |
212.8 |
% |
16.9 |
41.4 |
body weighing method |
0.0 |
0 |
76069 |
1545 |
Hsd:WI |
fetal body weight |
control condition |
Rothermund L, etal., J Hypertens. 2006 Sep 24(9). |
body mass |
not specified |
-6 days
| 0 |
0.31 |
g |
0.0 |
|
body weighing method |
0.0 |
0 |
108070 |
3115 |
Hsd:WI |
fetal body weight |
control condition |
Rothermund L, etal., J Hypertens. 2006 Sep 24(9). |
body mass |
not specified |
-2 days
| 0 |
2.26 |
g |
0.03 |
|
body weighing method |
0.0 |
0 |
108072 |
3115 |
Hsd:WI |
fetal body weight |
control condition |
Rothermund L, etal., J Hypertens. 2006 Sep 24(9). |
body mass |
not specified |
-4 days
| 0 |
0.87 |
g |
0.01 |
|
body weighing method |
0.0 |
0 |
108071 |
3115 |
Hsd:WI |
body weight |
vehicle control condition (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
body mass |
male |
119 days-126 days |
5 |
388.0 |
g |
16.82 |
37.6 |
body weighing method |
0.0 |
0 |
76041 |
1545 |
Hsd:WI |
body weight |
vehicle control condition (for 10 days) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
body mass |
male |
0 days
| 6 |
140.6 |
g |
0.53 |
1.3 |
body weighing method |
0.0 |
0 |
75951 |
1544 |
Hsd:WI |
body weight |
vehicle control condition (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
body mass |
male |
0 days
| 6 |
137.6 |
g |
0.45 |
1.1 |
body weighing method |
0.0 |
0 |
75952 |
1544 |
Hsd:WI |
change in body weight to body weight ratio |
bisphenol A (125 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
body mass |
male |
119 days-126 days |
6 |
201.5 |
% |
17.15 |
42.0 |
body weighing method |
0.0 |
0 |
76066 |
1545 |
Hsd:WI |
neonatal body weight |
control condition |
Rothermund L, etal., J Hypertens. 2006 Sep 24(9). |
body mass |
not specified |
1 days
| 0 |
6.58 |
g |
0.16 |
|
body weighing method |
0.0 |
0 |
108076 |
3115 |
Hsd:WI |
body weight |
octylphenol (250 mg/kg/d) (for 91 days) |
Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. |
body mass |
male |
119 days-126 days |
6 |
325.33 |
g |
12.4 |
30.37 |
body weighing method |
0.0 |
0 |
76050 |
1545 |